Joint Formulary & PAD

Oxybutynin - Hyperhidrosis

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Blue
Formulations :
  • Tablets
  • Tablets (slow release)
Associated Icons :
SPC
Restrictions / Comments :
Important

On recommendation from specialist team.

Immediate release tablets are preferred. Modified release may be used for patients with intolerable side effects to IR formulation

 

Status 2

Non Formulary
Formulations :
  • Elixir
  • Liquid
  • Oral solution
  • Oral suspension
  • Patches
Associated Icons :
NFD1
SPC
Restrictions / Comments :

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Oxybutynin
Indication :
Hyperhidrosis
Group Name :
Keywords :
antimuscarinics
Brand Names Include :
Ditropan, Lyrinel, Kentera
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0
Traffic Light Entries :
2

Committee Recommendations (0)

  • No records returned.

Other Indications

Below are listed other indications that Oxybutynin is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Hyperhidrosis.